Hepatic high-density lipoprotein secretion regulates the mobilization of cell-surface hepatic lipase

Biochemistry

Volumn 48, Issue 25, 2009, Pages 5994-6001

  Chatterjee, Cynthia ^a   Young, Elizabeth K ^a   Pussegoda, Kusala A ^a   Twomey, Erin E ^a   Pandey, Nihar R ^a   Sparks, Daniel L ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL LYSATES; CELL SURFACES; DILINOLEOYLPHOSPHATIDYLCHOLINE; HEPATOCYTES; HEPG2 CELLS; HIGH-DENSITY LIPOPROTEINS; HUMAN HEPATOCYTES; LINOLEIC ACID; OVER-EXPRESSION; PLASMA TRIGLYCERIDES; PROTEIN EXPRESSIONS; PROTEOGLYCANS;

FATTY ACIDS; PHOSPHOLIPIDS; POLYSACCHARIDES;

CELL MEMBRANES;

APOLIPOPROTEIN A1; DILINOLEOYLPHOSPHATIDYLCHOLINE; HIGH DENSITY LIPOPROTEIN; LINOLEIC ACID PHOSPHOLIPID; LIVER TRIACYLGLYCEROL LIPASE; MESSENGER RNA; PALMITOYLLINOLEOYLPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; HUMAN; HUMAN CELL; LIPOPROTEIN SECRETION; LIVER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOLIPOPROTEIN A-I; CELL LINE, TUMOR; CELLS, CULTURED; HEPATOCYTES; HUMANS; LIPASE; LIPOPROTEINS, HDL; LIVER; MEMBRANE PROTEINS; RNA, SMALL INTERFERING; TRIGLYCERIDES;

EID: 67649619331     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi802009e     Document Type: Article

References (31)

1. Connelly, P. W. (1999) The role of hepatic lipase in lipoprotein metabolism. Clin. Chim. Acta 286, 243-255.
2. Ramsamy, T. A., Neville, T. A., Chauhan, B. M., Aggarwal, D., and Sparks, D. L. (2000) Apolipoprotein A-I regulates lipid hydrolysis by hepatic lipase. J. Biol. Chem. 275, 33480-33486.
3. Ramsamy, T. A., Boucher, J., Brown, R. J., Yao, Z., and Sparks, D. L. (2003) HDL regulates the displacement of hepatic lipase from cell surface proteoglycans and the hydrolysis of VLDL triacylglycerol. J. Lipid Res. 44, 733-741. (Pubitemid 37279675)
4. Olivecrona, T., Bengtsson-Olivecrona, G., Ostergaard, P., Liu, G., Chevreuil, O., and Hultin, M. (1993) New aspects on heparin and lipoprotein metabolism. Haemostasis 23 (Suppl. 1), 150-160. (Pubitemid 23116288)
5. Olivecrona T. and Bengtsson-Olivecrona, G. (1989) Heparin and lipases, in Heparin: Chemical and biological properties, clinical applications (Lane, D. A., and Lindahl, U., Eds.) pp 335-361, CRC Press, Boca Raton, FL.
6. 2+/calmodulin-dependent protein kinase II in heparin-stimulated release of hepatic lipase activity from rat hepatocytes. Biol. Pharm. Bull. 28, 409-412.
7. Patsch, J. R., Miesenbock, G., Hopferwieser, T., Muhlberger, V., Knapp, E., Dunn, J. K., Gotto, A. M.Jr., and Patsch, W. (1992) Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler. Thromb. 12, 1336-1345.
8. Patsch, J. (1998) Influence of lipolysis on chylomicron clearance and HDL cholesterol levels. Eur. Heart J. 19 (Suppl. H), H2-H6.
9. Pandey, N. R., Renwick, J., Misquith, A., Sokoll, K., and Sparks, D. L. (2008) Linoleic acid-enriched phospholipids act through peroxisome proliferator-activated receptors alpha to stimulate hepatic apolipoprotein A-I secretion. Biochemistry 47, 1579-1587. (Pubitemid 351231208)
10. Pandey, N. R., and Sparks, D. L. (2008) Phospholipids as cardiovascular therapeutics. Curr. Opin. Invest. Drugs 9, 281-285.
11. Hopewell, S., Pandey, N. R., Misquith, A., Twomey, E., and Sparks, D. L. (2008) Phosphatidylinositol acts through mitogen-activated protein kinase to stimulate hepatic apoA-I secretion. Metabolism 57, 1677-1684.
12. Boucher, J. G., Nguyen, T., and Sparks, D. L. (2007) Lipoprotein electrostatic properties regulate hepatic lipase association and activity. Biochem. Cell Biol. 85, 696-708.
13. Gonzalez-Navarro, H., Nong, Z., Freeman, L., Bensadoun, A., Peterson, K., and Santamarina-Fojo, S. (2002) Identification of mouse and human macrophages as a site of synthesis of hepatic lipase. J. Lipid Res. 43, 671-675. (Pubitemid 34477892)
14. Sirvent, A., Verhoeven, A. J., Jansen, H., Kosykh, V., Darteil, R. J., Hum, D. W., Fruchart, J. C., and Staels, B. (2004) Farnesoid X receptor represses hepatic lipase gene expression. J. Lipid Res. 45, 2110-2115. (Pubitemid 40990906)
15. Rouhani, N., Young, E., Chatterjee, C., and Sparks, D. L. (2008) HDL composition regulates displacement of cell surface-bound hepatic lipase. Lipids 43, 793-804.
16. Boucher, J., Ramsamy, T. A., Braschi, S., Sahoo, D., Neville, T. A., and Sparks, D. L. (2004) Apolipoprotein A-II regulates HDL stability and affects hepatic lipase association and activity. J. Lipid Res. 45, 849-858. (Pubitemid 38552854)
17. Kirchmair, R., Ebenbichler, C. F., and Patsch, J. R. (1995) Postprandial lipaemia. Bailliere's Clin. Endocrinol. Metab. 9, 705-719.
18. Patsch, J. R., Prasad, S., Gotto, A. M. J., and Patsch, W. (1987) High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. J. Clin. Invest. 80, 341-347.
19. Olivecrona, T., Hultin, M., Bergo, M., and Olivecrona, G. (1997) Lipoprotein lipase: regulation and role in lipoprotein metabolism. Proc. Nutr. Soc. 56, 723-729.
20. Lewis, G. F., and Rader, D. J. (2005)New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ. Res. 96, 1221-1232.
21. Rader, D. J. (2006) Molecular regulation of HDL metabolism and function: implications for novel therapies. J. Clin. Invest. 116, 3090-3100.
22. Barter, P. J., and Rye, K. A. (2008) Is there a role for fibrates in the management of dyslipidemia in the metabolic syndrome?. Arterioscler., Thromb., Vasc. Biol. 28, 39-46.
23. Fruchart, J. C., Duriez, P., and Staels, B. (1999) Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis. Curr. Opin. Lipidol. 10, 245-257.
24. Simpson, H. S., Williamson, C. M., Olivecrona, T., Pringle, S., Maclean, J., Lorimer, A. R., Bonnefous, F., Bogaievsky, Y., Packard, C. J., and Shepherd, J. (1990) Postprandial lipemia, fenofibrate and coronary artery disease. Atherosclerosis 85, 193-202.
25. Simo, I. E., Yakichuk, J. A., and Ooi, T. C. (1993) Effect of gemfibrozil and lovastatin on postprandial lipoprotein clearance in the hypoalphalipoproteinemia and hypertriglyceridemia syndrome. Atherosclerosis 100, 55-64. (Pubitemid 23166008)
26. Schoonjans, K., Peinado-Onsurbe, J., Lefebvre, A. M., Heyman, R. A., Briggs, M., Deeb, S., Staels, B., and Auwerx, J. (1996) PPARR and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J. 15, 5336-5348. (Pubitemid 26336216)
27. Staels, B., Vu-Dac, N., Kosykh, V. A., Saladin, R., Fruchart, J. C., Dallongeville, J., and Auwerx, J. (1995) Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates. J. Clin. Invest. 95, 705-712.
28. Hertz, R., Bishara-Shieban, J., and Bar-Tana, J. (1995) Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III. J. Biol. Chem. 270, 13470-13475.
29. Kockx, M., Princen, H. M. G., and Kooistra, T. (1996) Studies on the role of PPAR in the fibrate-modulated gene expression of apolipoprotein A-I, plasminogen activator inhibitor 1, and fibrinogen in primary hepatocyte cultures from cynomolgus monkey. Ann. N.Y. Acad. Sci. 804, 711-712.
30. Jin, F. Y., Kamanna, V. S., and Kashyap, M. L. (1997) Niacin decreases removal of high-density lipoprotein apolipoprotein A-I but not cholesterol ester by Hep G2 cells - Implication for reverse cholesterol transport. Arterioscler., Thromb., Vasc. Biol. 17, 2020-2028.
31. Burgess, J. W., Neville, T. A., Rouillard, P., Harder, Z., Beanlands, D. S., and Sparks, D. L. (2005) Phosphatidylinositol increases HDL-C levels in humans. J. Lipid Res. 46, 350-355. (Pubitemid 40271099)